Sopharma's Jan – Apr Sales Revenues Up 13.4% y/y

986
Sopharma's Jan – Apr Sales Revenues Up 13.4% y/y

Sopharma Jsc's () sales revenues for the Jan – Apr period are up 13.40% y/y, which includes a 40.78% hike in foreign currency from export, x3news reports.

Sopahrma saw export grow 0.63% in April (in foreign currency) and 6.7% on the home market. The year on year growth is 3.34%.

Sales on the home market did not increase significantly due to the recent completion of a reconstruction in the ampule production, which had an impact on sales during the year's first two months.

Main shareholders are Donev Investments and Telso Jsc with 25.64% and 23.77%, while Telecomplect and Gramercy Emerging Markets Fund control 20.42% and 17.08%.

Non-consolidated profit stood at 6.54 mln leva (3.34 mln euros) as at March 31, 2008, which is 21% up compared with the corresponding period a year ago.

The stock fell 5% today to an average of 5.88 leva apiece.

Facebook Коментари

Добави коментар

Екипът на Profit.bg Ви благодари, че използвате кирилица за вашите коментари.
В случай, че коментарът Ви съдържа нецензурни квалификации и лични нападки или обиди на расова, сексуална, етническа или верска основа, той ще бъде изтрит от модератора на сайта.

Абонирайте се за електронния
информационен бюлетин на Profit.bg